Jose M Rubio
Overview
Explore the profile of Jose M Rubio including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
96
Citations
1168
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Salazar de Pablo G, Guinart D, Armendariz A, Aymerich C, Catalan A, Alameda L, et al.
Schizophr Bull
. 2024 Mar;
50(4):771-783.
PMID: 38491933
Background: The role of duration of untreated psychosis (DUP) as an early detection and intervention target to improve outcomes for individuals with first-episode psychosis is unknown. Study Design: PRISMA/MOOSE-compliant systematic...
12.
Kane J, Schoretsanitis G, Rubio J, Correll C
Schizophr Res
. 2024 Jan;
268:9-13.
PMID: 38290942
No abstract available.
13.
Rubio J, Lencz T, Cao H, Kraguljac N, Dhamala E, Homan P, et al.
Mol Psychiatry
. 2024 Jan;
29(4):929-938.
PMID: 38177349
To bring biomarkers closer to clinical application, they should be generalizable, reliable, and maintain performance within the constraints of routine clinical conditions. The functional striatal abnormalities (FSA), is among the...
14.
Salazar de Pablo G, Aymerich C, Guinart D, Catalan A, Alameda L, Trotta G, et al.
Psychol Med
. 2023 Dec;
54(4):652-662.
PMID: 38087871
Duration of untreated psychosis (DUP) has been associated with poor mental health outcomes. We aimed to meta-analytically estimate the mean and median DUP worldwide, evaluating also the influence of several...
15.
Cao H, Lencz T, Gallego J, Rubio J, John M, Barber A, et al.
Am J Psychiatry
. 2023 Aug;
180(11):827-835.
PMID: 37644811
Objective: Identification of robust biomarkers that predict individualized response to antipsychotic treatment at the early stage of psychotic disorders remains a challenge in precision psychiatry. The aim of this study...
16.
Rubio J, Lencz T, Cao H, Kraguljac N, Dhamala E, Homan P, et al.
medRxiv
. 2023 Jul;
PMID: 37503088
To bring biomarkers closer to clinical application, they should be generalizable, reliable, and maintain performance within the constraints of routine clinical conditions. The functional striatal abnormalities (FSA), is among the...
17.
Trevino B, Zarzuela F, Oliveira-Souto I, Rubio Maturana C, Serre-Delcor N, Aznar M, et al.
Open Forum Infect Dis
. 2023 Jul;
10(7):ofad338.
PMID: 37484898
A 17-year-old asymptomatic male from The Gambia presented for a routine health examination after migration to Spain. Laboratory diagnosis confirmed the presence of microfilariae. This unusual finding emphasizes the importance...
18.
Martin Ramirez A, Baron Argos L, Lanza Suarez M, Carmona Rubio C, Perez-Ayala A, Hisam S, et al.
Pathog Glob Health
. 2023 Jul;
118(1):80-90.
PMID: 37415348
Malaria is a parasitic disease distributed in tropical areas but with a high number of imported cases in non-endemic countries. The most specific and sensitive malaria diagnostic methods are PCR...
19.
Cao H, Barber A, Rubio J, Argyelan M, Gallego J, Lencz T, et al.
Neuroimage
. 2023 Jun;
277:120238.
PMID: 37364743
The majority of human connectome studies in the literature based on functional magnetic resonance imaging (fMRI) data use either an anterior-to-posterior (AP) or a posterior-to-anterior (PA) phase encoding direction (PED)....
20.
Rubio J, Guinart D, Kane J, Correll C
CNS Drugs
. 2023 Jun;
37(6):499-512.
PMID: 37261669
Background: Early non-response is a well-established prognostic marker but evidence-based and consistent recommendations to manage it are limited. The aim of this systematic review and meta-analysis was to generate evidence-based...